Sf. Brewster et Da. Gillatt, ADVANCED PROSTATE-CANCER - WHATS NEW IN HORMONAL MANIPULATION, British Journal of Hospital Medicine, 49(10), 1993, pp. 710
Prostate cancer is the second most common cause of male cancer deaths
in the UK. It is one of the few hormone-sensitive cancers and androgen
ablation produces subjective and objective tumour regression in 70-80
% of patients for a variable period. Orchidectomy remains the gold sta
ndard for treatment although there is an increasing number of equally
effective medical alternatives.